Investors tracking the semiconductor supply chain are increasingly focused on the companies that test and validate the chips powering artificial intelligence. AEHR (Aehr Test Systems) and FORM (FormFactor) both sit in this high-demand niche, yet their business models, growth profiles, and risk characteristics differ meaningfully. This comparison is relevant for growth-oriented traders evaluating momentum in AI-adjacent equipment names, as well as longer-horizon investors weighing valuation, diversification, and execution risk. By examining recent performance, catalysts, and relative market positioning, readers can better assess how these two stocks stack up in the current environment. I also checked this using Tickeron’s AI Screener to see how the stocks compare to others in the industry.
AEHR designs and markets test and burn-in systems used to verify and stabilize semiconductor devices in wafer, die, and packaged form. Its FOX-XP wafer-level and Sonoma package-level platforms are closely tied to accelerating demand for artificial-intelligence processors, data-center chips, and silicon photonics. In its most recent quarterly report, revenue surged roughly 200% year over year to about $33 million, and the company swung to a profit, with management raising its fiscal 2027 revenue outlook to approximately $150 million. Bookings of about $46.7 million and a backlog near $100.9 million underscore robust order momentum.
Despite these strong fundamentals, AEHR has exhibited notable volatility. Shares have climbed substantially on a year-to-date basis yet pulled back sharply in recent weeks, reflecting the tug-of-war between an accelerating business and a valuation that leaves little room for disappointment. A price-to-sales (P/S) ratio well above industry norms and a relatively concentrated customer base remain key watchpoints for investors.
FORM (FormFactor) is a leading supplier of probe cards and test systems used throughout semiconductor production, spanning high-bandwidth memory (HBM), dynamic random-access memory (DRAM), foundry and logic chips, and emerging co-packaged optics (CPO). In its most recent quarter, revenue grew about 38% year over year to approximately $280.5 million, with non-GAAP earnings per share (EPS) of $1.04 exceeding consensus estimates. Gross margins reached roughly 56.5%, reflecting strong operating leverage.
However, FORM shares declined after the report, as forward guidance implied only modest sequential growth and management flagged that its existing manufacturing footprint is nearing capacity. The ramp of its new Farmers Branch facility is expected to unlock additional output through 2027 but introduces near-term execution and cost pressures. Broader catalysts include multiyear partnerships with automated test equipment (ATE) leaders Teradyne and Advantest, plus expanding GPU and custom ASIC (application-specific integrated circuit) opportunities.
The core contrast between these two companies is specialization versus diversification. AEHR is a smaller, more concentrated play on wafer-level and package-level burn-in for AI and advanced silicon, offering higher growth potential but greater sensitivity to a narrower set of customers and orders. FORM operates across a broader set of applications — memory, logic, foundry, and photonics — which historically smooths demand swings and supports more consistent profitability.
On momentum, AEHR has delivered faster top-line acceleration, yet its price action has been far more volatile, and it still trades on a forward revenue multiple considerably above the broader semiconductor group. FORM grows more steadily and generates meaningful free cash flow, but its near-term story is tempered by capacity constraints and a softer sequential outlook. Risk profiles also diverge: AEHR carries concentration and valuation risk, while FormFactor's main challenges are execution-related, tied to scaling its new facility while preserving margins. From what I see, this distinction is important because it shapes how each name might respond to shifting AI demand cycles.
Based on observable factors such as trend consistency, stability, diversification, and relative positioning, Tickeron's AI would currently lean toward FORM. FormFactor's broader revenue base, consistent profitability, and steadier trend profile offer a more balanced risk-reward picture, even as its growth rate moderates near term. AEHR presents compelling upside tied to AI-driven demand, but its concentrated exposure and elevated valuation introduce greater uncertainty. The verdict reflects a probabilistic assessment of current conditions rather than a definitive prediction, and both names merit ongoing review as catalysts unfold. I’m watching this closely as new order data comes in.
In my own research, I often turn to Tickeron’s AI Trading Bots to review how different automated strategies have performed across names like these. The platform provides historical records and varied approaches that add useful context when weighing short-term swings against longer trends. AI Trading Bots
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 50-day moving average for AEHR moved below the 200-day moving average on November 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 74 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The Moving Average Convergence Divergence Histogram (MACD) for AEHR turned negative on November 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 34 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 89%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for AEHR entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for AEHR's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 243 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
AEHR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.970) is normal, around the industry mean (5.670). AEHR has a moderately low P/E Ratio (-232.913) as compared to the industry average of (68.795). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment